{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T06:02:35Z","timestamp":1771480955962,"version":"3.50.1"},"reference-count":74,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100003887","name":"International Myeloma Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003887","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2023,12,31]]},"DOI":"10.1080\/13696998.2022.2144056","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T11:34:19Z","timestamp":1667907259000},"page":"110-119","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["Systematic literature review of health economic models developed for multiple myeloma to support future analyses"],"prefix":"10.1080","volume":"26","author":[{"given":"Mimi","family":"Choon-Quinones","sequence":"first","affiliation":[{"name":"International Myeloma Foundation, North Hollywood, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tam\u00e1s","family":"Zelei","sequence":"additional","affiliation":[{"name":"Syreon Research Institute, Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6513-5147","authenticated-orcid":false,"given":"Bertalan","family":"N\u00e9meth","sequence":"additional","affiliation":[{"name":"Syreon Research Institute, Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manna","family":"T\u00f3th","sequence":"additional","affiliation":[{"name":"Syreon Research Institute, Budapest, Hungary"},{"name":"Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao Yang","family":"Jia","sequence":"additional","affiliation":[{"name":"Syreon Research Institute, Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike","family":"Barnett","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of British Columbia, Vancouver, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Keown","sequence":"additional","affiliation":[{"name":"Syreon Research Institute, Budapest, Hungary"},{"name":"Department of Medicine, University of British Columbia, Vancouver, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Durie","sequence":"additional","affiliation":[{"name":"International Myeloma Foundation, North Hollywood, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Luc","family":"Harousseau","sequence":"additional","affiliation":[{"name":"Chemin de la Censive du Tertre, University of Nantes, Nantes, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Hose","sequence":"additional","affiliation":[{"name":"Vrije Universiteit Brussel (VUB), Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7762-2607","authenticated-orcid":false,"given":"Zolt\u00e1n","family":"Kal\u00f3","sequence":"additional","affiliation":[{"name":"Syreon Research Institute, Budapest, Hungary"},{"name":"Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,1,9]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1011442"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21590"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2018.01.015"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2020.1827253"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-020-02541-1"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.0049"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx096"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.07.008"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-015-0198-x"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2003.9.1.53"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001744"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12571"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2011.611841"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.3109\/0284186X.2015.1096021"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-017-0776-1"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2018.1445634"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-021-01251-8"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.04.005"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.5867\/medwave.2018.03.7220"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2017.08.2584"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-012-0395-6"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-017-0581-6"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2019.1620947"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.608685"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.3747\/co.19.1004"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-021-01068-9"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2011-0380"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2010.543125"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2010.01526.x"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2016.1194278"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2020.04.1222"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2021.05.015"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.2217\/cer-2019-0052"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2021.034"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2017.08.253"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2020.04.1571"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2021.27.12.1691"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2021.1970522"},{"key":"e_1_3_5_41_1","volume-title":"Treatment options for relapsed or refractory multiple myeloma: effectiveness, value, and value-based price benchmarks","author":"Ollendorf D","year":"2016","unstructured":"Ollendorf D, Chapman R, Khan S. Treatment options for relapsed or refractory multiple myeloma: effectiveness, value, and value-based price benchmarks. Boston: Institute for Clinical and Economic Review; 2016."},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-019-0574-5"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.12421"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01849"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2017.08.010"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.2147\/CEOR.S152437"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2015.1115407"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13497"},{"issue":"2","key":"e_1_3_5_49_1","first-page":"83","article-title":"Long-term effectiveness and cost effectiveness of multiple myeloma treatment strategies for elderly transplant-ineligible patients in Serbia","volume":"59","author":"Vuki\u0107evi\u0107 \u0110","year":"2020","unstructured":"Vuki\u0107evi\u0107 \u0110, Rochau U, Savi\u0107 A, et\u00a0al. Long-term effectiveness and cost effectiveness of multiple myeloma treatment strategies for elderly transplant-ineligible patients in Serbia. Zdr Varst. 2020;59(2):83\u201391.","journal-title":"Zdr Varst"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40487-021-00169-x"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021015220"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2019.12.007"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-021-01699-6"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2018.05.012"},{"key":"e_1_3_5_55_1","unstructured":"National Institute of Health and Care Excellence (NICE). Bortezomib and thalidomide for the first line treatment of multiple myeloma TA228 27; 2011. Available from: https:\/\/www.nice.org.uk\/guidance\/ta228\/resources\/bortezomib-and-thalidomide-for-the-firstline-treatment-of-multiple-myeloma-pdf-82600316845765"},{"key":"e_1_3_5_56_1","unstructured":"National Institute of Health and Care Excellence (NICE). Bortezomib for induction therapy in multiple myeloma before high-dose chemotherapy and autologous stem cell transplantation TA311 23; 2014. Available from: https:\/\/www.nice.org.uk\/guidance\/ta311\/resources\/bortezomib-for-induction-therapy-in-multiple-myeloma-before-highdose-chemotherapy-and-autologous-stem-cell-transplantation-pdf-82602421404613"},{"key":"e_1_3_5_57_1","unstructured":"National Institute of Health and Care Excellence (NICE). Panobinostat for treating multiple myeloma after at least 2 previous treatments TA380; 2016 [cited 2016 Jan 27]. Available from: https:\/\/www.nice.org.uk\/guidance\/ta380\/resources\/panobinostat-for-treating-multiple-myeloma-after-at-least-2-previous-treatments-pdf-82602842988229"},{"key":"e_1_3_5_58_1","unstructured":"National Institute of Health and Care Excellence (NICE). Isatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma TA658; 2020 [cited 2020 Nov 18]. Available from: https:\/\/www.nice.org.uk\/guidance\/ta658\/resources\/isatuximab-with-pomalidomide-and-dexamethasone-for-treating-relapsed-and-refractory-multiple-myeloma-pdf-82609205373637"},{"key":"e_1_3_5_59_1","unstructured":"Canadian Agency for Drugs and Technologies in Health (CADTH). Darzalex in combo with bortezomib melphalan and prednisone for multiple myeloma (newly diagnosed) \u2013 final economic guidance report; 2019 [updated 2019 Sep 16]. Available from: https:\/\/www.cadth.ca\/sites\/default\/files\/pcodr\/Reviews2019\/10148Daratumumab%2BVMPforMM_fnEGR_NOREDACT-ABBREV_Post_29Aug2019_final.pdf"},{"key":"e_1_3_5_60_1","unstructured":"Canadian Agency for Drugs and Technologies in Health (CADTH). Revlimid (in combo) bortezomib\u2009+\u2009dexamethasone for newly diagnosed multiple myeloma \u2013 final economic guidance report; 2019 [updated 2019 Jul 5]. Available from: https:\/\/www.cadth.ca\/sites\/default\/files\/pcodr\/Reviews2019\/10141LenalidomideBorDexMM_fnEGR_NOREDACT-ABBREV_EC-Post_19Jun2019_final.pdf"},{"key":"e_1_3_5_61_1","unstructured":"Canadian Agency for Drugs and Technologies in Health (CADTH). Ninlaro for multiple myeloma (2nd-beyond) \u2013 final economic guidance report; 2019 [updated 2019 Jul 22]. Available from: https:\/\/www.cadth.ca\/sites\/default\/files\/pcodr\/Reviews2019\/10164IxazomibMM_fnEGR_NOREDACT-ABBREV_Post_05Jul2019_final.pdf"},{"key":"e_1_3_5_62_1","unstructured":"Canadian Agency for Drugs and Technologies in Health (CADTH). Pomalyst in combination with dexamethasone and bortezomib for multiple myeloma (second-line or beyond) \u2013 final economic guidance report; 2019 [updated 2019 Oct 3]. Available from: https:\/\/www.cadth.ca\/sites\/default\/files\/pcodr\/Reviews2019\/10165PomalidomideBortezomibMM_fnEGR_NOREDACT-ABBREV_EarlyConv_Post_18Sep2019_final.pdf"},{"key":"e_1_3_5_63_1","unstructured":"World Bank Country and Lending Groups; 2022. Available from: https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2004.01.019"},{"key":"e_1_3_5_65_1","first-page":"1","article-title":"A systematic review of economic evaluations of treatment regimens in multiple myeloma","volume":"21","author":"Asrar MM","year":"2020","unstructured":"Asrar MM, Lad DP, Prinja S, et\u00a0al. A systematic review of economic evaluations of treatment regimens in multiple myeloma. Expert Rev Pharmacoecon Outcomes Res. 2020;21:1\u201311.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00860"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2008.00489.x"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.13180.1"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.313.7052.275"},{"key":"e_1_3_5_70_1","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198529446.001.0001","volume-title":"Methods for the economic evaluation of health care programme","author":"Drummond MF","year":"2005","unstructured":"Drummond MF, Sculpher MJ, Stoddart GL, et\u00a0al. Methods for the economic evaluation of health care programme. 3rd ed. Oxford: Oxford University Press; 2005.","edition":"3"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12384"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2013.02.002"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2014.12.017"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462313000615"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2015.09.2607"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2022.2144056","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T10:15:55Z","timestamp":1701944155000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2022.2144056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,9]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12,31]]}},"alternative-id":["10.1080\/13696998.2022.2144056"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2022.2144056","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-05-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}